APA (7th ed.) Citation

Y, C., Y, H., X, G., Y, L., J, L., L, C., . . . C, C. (2020). CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors. Frontiers in immunology, 11, 1620. https://doi.org/10.3389/fimmu.2020.01620

Chicago Style (17th ed.) Citation

Y, Chen, et al. "CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors." Frontiers in Immunology 11 (2020): 1620. https://doi.org/10.3389/fimmu.2020.01620.

MLA (9th ed.) Citation

Y, Chen, et al. "CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors." Frontiers in Immunology, vol. 11, 2020, p. 1620, https://doi.org/10.3389/fimmu.2020.01620.